Related Experiment Video
Updated: Jan 6, 2026

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
Published on: January 29, 2021
Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
Clemens Küpper1, Johanna Heinrich2, Katharina Kamm2
1From the Department of Neurology (C.K., J.H., K.K., A.S.), University Hospital, Ludwig Maximilians University; Laboratory for Leukemia Diagnostics (V.B.), Department of Medicine III, University Hospital, Ludwig Maximilians University; and Division of Clinical Pharmacology (S.R.), University Hospital, Ludwig Maximilians University, Munich, Germany. Clemens.Kuepper@med.uni-muenchen.de.
No abstract available in PubMed .
More Related Videos
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents